Arkansas 2025 Regular Session

Arkansas House Bill HB1889

Introduced
3/20/25  
Refer
3/20/25  
Report Pass
4/1/25  
Engrossed
4/2/25  
Refer
4/2/25  
Report Pass
4/3/25  
Enrolled
4/10/25  

Caption

To Amend The Limitations On Access To A Dispensary Or Cultivation Facility; And To Authorize A Dispensary To Deliver Orders Via A Delivery Vehicle Or Via A Drive-through Window.

Summary

HB1889 would amend Arkansas law governing medical marijuana dispensaries and cultivation facilities. The bill relaxes certain access rules for restricted areas by allowing invited visitors who present government-issued identification, wear a visitor tag, and are escorted as required, while also preserving requirements for logbooks and video surveillance. It also continues to allow parents or caregivers with the proper registry credentials to bring children into dispensaries or cultivation facilities for the purpose of purchasing usable marijuana. The bill’s main operational change is to authorize dispensaries to deliver usable marijuana to qualified patients or designated caregivers in two new ways: by delivery vehicle to a residential address and through a drive-through window at the dispensary. Both delivery methods must occur on the same day the order is processed, require separate packaging and delivery tickets, and require staff to verify registry identification cards before completing the transaction. The bill also permits a single employee to staff a delivery vehicle if additional security measures such as GPS or real-time camera monitoring are in place, and it directs the Alcoholic Beverage Control Division to adopt implementing rules.

Impact

HB1889 would amend Arkansas Code § 20-56-303 and add a new section to Title 20, Chapter 56, Subchapter 3, expanding the permitted methods for dispensing medical marijuana and adjusting access rules for dispensary and cultivation facility restricted areas. It would affect licensed dispensaries, cultivation facilities, qualified patients, designated caregivers, and the Alcoholic Beverage Control Division, which would gain rulemaking authority to implement the new delivery provisions. The bill would also create new compliance obligations related to identification checks, manifests, packaging, surveillance, and secure drive-through operations.

Sentiment

The available voting history suggests the bill had meaningful support but also notable opposition. It passed third reading in the House 51-31 and later passed third reading in the Senate 19-15, indicating a divided but favorable reception overall. No committee transcript is available, so the recorded votes are the main indicator of sentiment, and they show the measure was supported by a majority while still drawing substantial resistance.

Contention

The likely points of contention are the expansion of medical marijuana access and the security implications of allowing home delivery and drive-through dispensing. Supporters appear to favor increased convenience for qualified patients and caregivers, especially those with mobility or transportation barriers, while opponents may be concerned about diversion, verification, public safety, and the appropriateness of loosening restrictions around dispensary operations. The narrow margins in both chambers suggest these issues were politically sensitive and closely contested.

Companion Bills

No companion bills found.

Similar Bills

NJ S3146

Authorizes cannabis cultivation on land receiving farmland assessment; technical assistance for cannabis businesses; and economic incentives for certain businesses operating in impact zones.

NJ A1131

Authorizes cannabis cultivation on land receiving farmland assessment.

AZ SB1057

Marijuana; rural opportunity initiative

AZ SB1713

Marijuana; dual licensees; rural communities

IL HB2557

CANNABIS DELIVERY LICENSE ACT

AZ SB1363

marijuana; rural opportunity initiative

NJ S1794

Requires Cannabis Regulatory Commission to monitor prices and to establish price cap on prices, under certain conditions, regarding medical cannabis cultivators, manufacturers, dispensaries, and clinical registrants.

NJ A427

Requires Cannabis Regulatory Commission to monitor prices and to establish price cap on prices, under certain conditions, regarding medical cannabis cultivators, manufacturers, dispensaries, and clinical registrants.